PLRX Iron Condor Strategy
PLRX (Pliant Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a trials. The company also develops PLN-1474, a small-molecule selective inhibitor of avß1, which completed Phase 1 clinical trial for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis. In addition, it is developing two additional preclinical integrin-based programs, which include an oncology program, as well as a program for an allosteric agonistic monoclonal antibody against an undisclosed integrin receptor for treatment of muscular dystrophies, including duchenne muscular dystrophy. Pliant Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.
PLRX (Pliant Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $72.4M, a beta of 1.21 versus the broader market, a 52-week range of 1.09-1.95, average daily share volume of 537K, a public-listing history dating back to 2020, approximately 171 full-time employees. These structural characteristics shape how PLRX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.21 places PLRX roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a iron condor on PLRX?
An iron condor sells a call spread and a put spread at strikes outside spot, collecting net premium that is kept if the underlying stays inside the inner short strikes.
Current PLRX snapshot
As of May 15, 2026, spot at $1.13, ATM IV 20.90%, IV rank 0.08%, expected move 5.99%. The iron condor on PLRX below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this iron condor structure on PLRX specifically: PLRX IV at 20.90% is on the cheap side of its 1-year range, which means a premium-selling PLRX iron condor collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 5.99% (roughly $0.07 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated PLRX expiries trade a higher absolute premium for lower per-day decay. Position sizing on PLRX should anchor to the underlying notional of $1.13 per share and to the trader's directional view on PLRX stock.
PLRX iron condor setup
The PLRX iron condor below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With PLRX near $1.13, the first option leg uses a $1.19 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed PLRX chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 PLRX shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Sell 1 | Call | $1.19 | N/A |
| Buy 1 | Call | $1.24 | N/A |
| Sell 1 | Put | $1.07 | N/A |
| Buy 1 | Put | $1.02 | N/A |
PLRX iron condor risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals the net credit times 100 inside the inner strikes; max loss equals wing width minus credit times 100. Two breakevens at inner strikes plus and minus the credit.
PLRX iron condor payoff curve
Modeled P&L at expiration across a range of underlying prices for the iron condor on PLRX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use iron condor on PLRX
Iron condors on PLRX are a delta-neutral premium-collection structure that profits if PLRX stock stays inside the inner short strikes; short strikes typically sit near 1 standard deviation from spot.
PLRX thesis for this iron condor
The market-implied 1-standard-deviation range for PLRX extends from approximately $1.06 on the downside to $1.20 on the upside. A PLRX iron condor is a delta-neutral premium-collection structure that pays off when PLRX stays inside the inner short strikes through expiration; the wing width should reflect the trader's tolerance for the maximum loss scenario where the underlying breaches an outer strike. Current PLRX IV rank near 0.08% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on PLRX at 20.90%. As a Healthcare name, PLRX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to PLRX-specific events.
PLRX iron condor positions are structurally neutral / range-bound; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. PLRX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move PLRX alongside the broader basket even when PLRX-specific fundamentals are unchanged. Short-premium structures like a iron condor on PLRX carry tail risk when realized volatility exceeds the implied move; review historical PLRX earnings reactions and macro stress periods before sizing. Always rebuild the position from current PLRX chain quotes before placing a trade.
Frequently asked questions
- What is a iron condor on PLRX?
- A iron condor on PLRX is the iron condor strategy applied to PLRX (stock). The strategy is structurally neutral / range-bound: An iron condor sells a call spread and a put spread at strikes outside spot, collecting net premium that is kept if the underlying stays inside the inner short strikes. With PLRX stock trading near $1.13, the strikes shown on this page are snapped to the nearest listed PLRX chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are PLRX iron condor max profit and max loss calculated?
- Max profit equals the net credit times 100 inside the inner strikes; max loss equals wing width minus credit times 100. Two breakevens at inner strikes plus and minus the credit. For the PLRX iron condor priced from the end-of-day chain at a 30-day expiry (ATM IV 20.90%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a PLRX iron condor?
- The breakeven for the PLRX iron condor priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current PLRX market-implied 1-standard-deviation expected move is approximately 5.99%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a iron condor on PLRX?
- Iron condors on PLRX are a delta-neutral premium-collection structure that profits if PLRX stock stays inside the inner short strikes; short strikes typically sit near 1 standard deviation from spot.
- How does current PLRX implied volatility affect this iron condor?
- PLRX ATM IV is at 20.90% with IV rank near 0.08%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.